Medical research

Research examines chronic sinusitis

According to the National Institutes for Health, chronic sinusitis, also known as chronic rhinosinusitis (CRS), affects approximately 14.6% of the United States population and is currently the fifth most common condition ...

Immunology

Verapamil benefits chronic rhinosinusitis with nasal polyps

(HealthDay)—For patients with chronic rhinosinusitis with nasal polyps (CRSwNP), the first-generation inhibitor of epithelial P-glycoprotein (P-gp; an efflux pump that is overexpressed in CRSwNP), verapamil hydrochloride ...

Immunology

FDA expands use of asthma med Xolair to treat food allergies

People threatened by accidental exposure to foods they're allergic to may have a new weapon of defense: On Feb. 16, the U.S. Food and Drug Administration expanded the use of the asthma drug Xolair to help prevent anaphylactic ...

Diseases, Conditions, Syndromes

Two biomarkers may aid diagnosis of rhinosinusitis

(HealthDay)—Two protein markers may serve as biomarkers for chronic rhinosinusitis, according to a proof-of-principle study published in The Laryngoscope.

Diseases, Conditions, Syndromes

Clinical decision rules accurately ID rhinosinusitis

(HealthDay)—Clinical decision rules can be used to diagnose acute rhinosinusitis and acute bacterial rhinosinusitis, according to a study published in the July/August issue of the Annals of Family Medicine.

page 3 from 4